Drug price, dosage and safety: Real-world evidence of oral hypoglycemic agents

Yu-Shiuan Lin, Min-Ting Lin and Shou-Hsia Cheng

Health Policy, 2019, vol. 123, issue 12, 1221-1229

Abstract: Drug price reduction is one of the major policies to restrain pharmaceutical expenses worldwide. This study explores whether there is a relationship between drug price and clinical quality using real-world data.

Keywords: Drug price policy; Pharmacoeconomics; Clinical quality; Comparative effectiveness research; Oral hypoglycemic agents (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851019301897
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:123:y:2019:i:12:p:1221-1229

DOI: 10.1016/j.healthpol.2019.08.005

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().